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Backround/aim: Cyclophosphamide (CP) is a drug used for treatment of many malignant diseases. However, it can cause serious
side effects such as hemorrhagic cystitis and male infertility. Hydrogen sulfide (H2S) is a gaseous mediator and is suggested to have
antioxidant, antiinflammatory, and antiapoptotic effects. In this study, dose-dependent effects of H2S donor sodium hydrosulfide
(NaHS) on cyclophosphamide-induced hemorrhagic cystitis and testicular dysfunction were investigated in rats.
Material and methods: Rats were divided into 5 groups (n = 8): control, CP, NaHS25 μmol/kg, NaHS50 μmol/kg, and NaHS100 μmol/
kg. After treatment for 7 days intraperitoneally (ip), a single ip dose of CP 200 mg/kg was given on the 8th day. Then, treatment was
continued for 7 days. In bladder and testicular tissues, IL 6, IL 10, cGMP, NO, H2S, FSH, LH, and testosterone levels were measured
by ELISA. Histopathological examination with H&E staining, as well as immunohistochemical staining for acrolein in bladder and
caspase-3 and APAF-1 in testis were performed.
Results: NaHS prevented the increased IL 6 and IL 10 values induced by CP as well as prevented the decrease in cGMP values associated
with CP. There was no significant change in FSH values, but the LH value, which increased with CP, decreased with 25, 50, and 100
µmol/kg NaHS. In contrast, testosterone decreased in the CP group and increased in the treatment groups. NaHS was effective in many
biochemical and histopathological parameters at 25 and 50 µmol/kg doses, and this effect decreased at 100 µmol/kg dose.
Conclusion: H2S has a protective and therapeutic effect on hemorrhagic cystitis and testicular dysfunction induced by cyclophosphamide.
It can be suggested that H2S is a promising molecule in facilitating cancer treatment.
Key words: Cyclophosphamide, hydrogen sulfide, testis, bladder

1. Introduction
Cyclophosphamide (CP) is currently still an antineoplastic
used for treatment of many malignant diseases [1].
However, in addition to the necessity for its use, it
causes serious and uncomfortable side effects in patient.
Hemorrhagic cystitis and testis injury in males may
be listed among these side effects [2]. Hemorrhagic
cystitis is a painful disease causing many problems for
the patient and unfortunately it is frequently observed
during cyclophosphamide treatment [3]. The side effects
of the drug are reported to be due to the active metabolite
of acrolein [3]. Acrolein is excreted in urine [4,5]. As a
result, the organ with most exposure to this metabolite is
the bladder. During treatment with cyclophosphamide,
epithelial edema, ulceration, hemorrhage and leukocyte

infiltration are commonly observed in the bladder
[4–6]. At the same time, there are studies stating that
cyclophosphamide negatively affects fertility [7,8]. Many
male cancer patients apply for sperm freezing procedures
before beginning treatment to maintain reproductive
capability. This is a sad and troubling situation for
these people. This effect, observed as a side effect of CP
in humans, is the same in experimental animals. As a
result, many studies have used CP as a model with the
aim of inducing hemorrhagic cystitis in experimental
animals. Hydrogen sulfide (H2S) is a mediator with gas
structure and is produced by mammalian tissue. H2S is
synthesized from L-cysteine by two pyridoxal 5-phosphate
linked enzymes, in other words cystathionine β synthase
(CBS) and cystathionine γ lyase (CSE), and an enzyme
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independent of phosphate 3-mercaptopurine sulfur
transferase (3-MST). H2S is reported to affect processes
like apoptosis, inflammation, angiogenesis, proliferation,
metabolism, oxygen sensitivity, and oxidative stress [9,10].
H2S is thought to play an important role in formation of
visceral pain. However, antinociceptive effects have been
identified. This is thought to occur through endogenous
H2S upregulation by CSE via activation of the Ca (v) 3.2
channel, one of the Ca (+2) channels [11]. The analgesic
effect is thought to be linked to opening of the K (ATP)
channels [12]. Many studies have shown that H2S prevents
inflammation and oxidative stress in ischemia/reperfusion
injury and may have therapeutic effect in many organs and
metabolic diseases. Additionally, there are studies which
found H2S relaxed the corpus cavernosum in rabbits and
increased intracavernosal pressure in animals [13,14].
Additionally, it was shown to induce the same effects in
the human corpus cavernosum [15]. These effects are
thought to occur through L-cysteine amino acid. In fact,
in a study by La Fuante et al. H2S relaxed penile arterial
and cavernous tissues in males with erectile dysfunction
and they presented evidence that these effects occurred
with L-cysteine mediation. The researchers proved that
H2S contributed to cGMP production [16].
CP is a promising medication for many cancer patients
and considering it is frequently used for this type of patient,
the lack of observation of side effects will suit patients in
terms of quality of life. In fact, serious side effects may
represent a reason for patients to abandon this medication
or leave them struggling with side effects due to necessity.
H2S may be promising in terms of protecting patients from
these side effects or preventing the occurrence of side
effects.
Based on all this information, this study aimed to
investigate the therapeutic and protective effects of H2S
against hemorrhagic cystitis and testicular injury, serious
side effects of the cancer drug cyclophosphamide, in male
rats.
2. Materials and methods
2.1. Experimental animals and groups
In this study, 40 male Sprague Dawley rats weighing 240–
280 g were used. The rats were housed at room temperature
(24 ± 2 °C) with fixed limits of 55% ± 15% relative humidity
and 12 h/12 h light/dark cycle. Water and standard rat
feed were administered ad libitum. All procedures related
to animals were completed in accordance with national
and international regulations about animal experiments.
The study was completed in Dumlupınar University
Experimental Animals Breeding Research and Application
Center and Dumlupınar University Advanced Technologies
Design, Research and Development Center.

The experimental study groups were organized as
follows (n = 8):
CP: cyclophosphamide, PS: physiologic serum, NaHS:
sodium hydrosulfide H2S donor.
Subjects were used with the following aims.
Group 1 (Control): 0.2 mL PS intraperitoneal (ip) for
15 days duration.
Group 2 (CP): 0.2 mL PS ip 7 days before and 7 days
after + 200 mg/kg ip single dose CP on the 8th day.
Group 3 (CP + NaHS25): 25 µmol/kg NaHS ip 7 days
before and 7 days after + 200 mg/kg ip single dose CP on
the 8th day.
Group 4 (CP + NaHS50): 50 µmol/kg NaHS ip 7 days
before and 7 days after + 200 mg/kg ip single dose CP on
the 8th day.
Group 5 (CP + NaHS100): 100 µmol / kg NaHS ip 7
days before and 7 days after + 200 mg/kg ip single dose CP
on the 8th day.
Control group rats were administered 0.2 mL PS. The
cyclophosphamide group were administered 0.2 mL PS for
7 days, then 200 mg/kg ip single dose cyclophosphamide
on the 8th day (6) and finally 0.2 mL PS ip for 7 days again
to complete 15 days. The treatment groups had the same
protocol administered with NaHS of 25, 50, and 100 µmol/
kg doses [17].
Animals were weighed 24 h after treatment and
anesthesia was induced with ketamine (70 mg/kg ip,
Ketalar, Pfizer) and xylazine (10 mg/kg ip, Alfazyne).
Intracardiac blood was taken for euthanasia of animals.
Blood samples were centrifuged at 1000 g for 20 min and
serum was stored at 20 °C. The bladder and both testes of
animals were obtained. One testis was weighed and stored
at –20 °C for dry weight measurement. The other testis
was divided into 2 pieces and stored for histopathologic
examination and to create biochemical homogenates. The
bladders of the animals were divided into 3 pieces. The 1st
piece was used for histopathologic analysis, the 2nd piece
was used to prepare homogenate for biochemical testing
purposes, and the 3rd piece was weighed and stored at –20
°C and used to measure dry weight later.
2.2. Body and organ weights
Animals were weighed before and after the experiment.
Weight results were recorded. Changes in body weight
were calculated as percentages (BW% = (BW2–BW1)/100).
Frozen testis and bladder samples were dried in an oven at
60 °C for 12 h. Dry weights were recorded and dry/wet
weight ratios were calculated.
2.3. Histopathologic investigations
The bladder and testis were stored in 10% neutral formalin
solution. Tissues were later submerged in paraffin blocks,
sections were taken and stained with hematoxylin and
eosin. With the aim of showing the presence of apoptotic
cells, APAF-1 and caspase 3 stains were used. Additionally,
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the presence of acrolein in the bladder walls was assessed.
For this purpose, acrolein staining was used. The Gray
criteria were used for histopathologic bladder scoring.
Gray scoring is grade 0: normal epithelium, grade 1:
moderate degree of submucosal edema, moderate degree
hemorrhage and low amounts of ulceration, and grade 2:
cell infiltration, fibrin deposition, severe hemorrhage, and
countless ulceration [18].
2.4. Investigation of testis and bladder homogenates
2.4.1. Preparation of testis and homogenates
Tissues taken from the bladder and testis were
homogenized in 5% Triton X-100 and phosphate with 1:1
ratio buffered 1 mL mixture. The homogenized tissue was
later centrifuged at 1000 g for 10 min and the supernatant
was used for biochemical analyses.
2.4.2. Measurement of H2S, NO (nitric oxide), cGMP,
IL 6 (interleukin 6), IL 10 (interleukin 10), FSH (follicle
stimulating hormone), LH (luteinizing hormone), and
testosterone
H2S, NO, cGMP, IL 6, IL 10, LH, FSH, and testosterone
levels were measured with the aid of commercial kits. The
procedures were completed in line with the guidelines in
the commercial kits.
2.4.3. Protein amounts in homogenates
This was measured with a maestrogen-maestronano
spectrophotometer.
2.5. Statistical analysis
Results in are given as mean ± SD and median (%25)–(%75).
Data were analyzed in the SPSS program v: 21.0 (IBM
Corp., Armonk, NY) using one-way analysis of variance
test (ANOVA) (posthoc Dunnett test). Comparison of
histopathologic data used the Kruskal–Wallis (posthoc
Dunn method) test. Significance was accepted as p < 0.05.
3. Results
3.1. Body weight values
Body weight values is shown in Table 1. When body weight
(BW) ratios are investigated, the cyclophosphamide (CP)
group had severe body weight loss compared to the control
group (p < 0.001). The higher body weight loss in the
NaHS50 group is noteworthy. There was significant body
weight loss, though at lower rates, in the NaHS100 group.
Relative bladder weight was calculated by dividing
the wet bladder weight by the final BW. Significant
variation was not identified between the groups in terms
of relative bladder weight. However, relative testis weight
was significantly increased in CP, NaHS25, and NaHS50
groups compared to controls (p < 0.01).
Wet/dry bladder weights were observed to be
significantly increased in the groups administered 50 and
100 µmol/kg NaHS compared to controls (p < 0.001). There
was no significant variation in wet/dry testis weights.

1532

3.2. Biochemical analysis
3.2.1. Interleukin values (IL)
Interleukin values is shown in Figure 1. When IL 10 and
IL 6 values are examined, the IL 10 values increased in
testis tissue in the CP group. However, the same value was
lower in the groups administered 25, 50, and 100 µmol/
kg NaHS compared to the CP group (p < 0.01) (Figure
1A). The greatest reduction was noted in the 50 µmol/kg
NaHS group. There were no significant changes in the IL
10 values in the bladder. However, it is notable that the
mean values in the 25 and 50 µmol/kg NaHS groups were
closest to the control group (Figure 1B).
When examined for IL 6 values, we can see IL 6
was elevated in the CP group (p < 0.01). There was a
pronounced fall in this value in the groups administered
25, 50, and 100 µmol/kg NaHS compared to the CP group.
Again, when assessed in terms of mean values, the greatest
reduction was observed in the 50 µmol/kg NaHS group
(Figure 1C). Though there was no statistically significant
variation of IL6 in bladder tissue, in terms of mean values
the greatest reduction was observed in the 50 µmol/kg
NaHS group (Figure 1D).
3.2.2. Cyclic guanosine monophosphate (cGMP) values
cGMP values is shown in Table 2. When cGMP values
are investigated, values for the bladder were identified
to have significant falls in the CP, NaHS25 and NaHS50
groups compared to the control group (p < 0.01). When
the NaHS100 group is compared with other treatment
groups, a significant elevation is present (p < 0.01). In testis
tissue, the cGMP values in the CP group were observed
to be significantly low. However, this value significantly
increased, especially in the group administered 50 µmol/
kg NaHS. The same increase was observed in the other
treatment groups, with the highest increase in mean values
observed in the 50 µmol/kg NaHS group.
3.2.3. Nitric oxide (NO)-hydrogen sulfide (H2S) values
Nitric oxide (NO)-hydrogen sulfide (H2S) values is shown
in Table 2. When NO and H2S values are investigated,
the NO values in testis tissue appeared to be significantly
elevated in the NaHS50 group compared to both the
control group and the CP group (p < 0.01). The NaHS100
group had a significant fall compared to values in the
NaHS50 group (p < 0.01). Similarly, in bladder tissue there
was a significant elevation in the NaHS50 group (p < 0.05).
The H2S values in testis tissue were significantly
elevated in all three treatment groups compared to the
control and CP groups (p < 0.001). The greatest increase
in mean value was observed in the NaHS100 group. When
bladder tissue is examined, there were significant increases
in the 50 and 100 µmol/kg NaHS groups compared to the
control and CP groups (p < 0.01).
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Table 1. Body and organ weights in rats.

BW%

Relative bladder
weight (mg/g)

Dry/wet bladder
weight (mg/g)

Relative testis
weight (mg/g)

Dry/wet testis
weight
(mg/g)

Group

Mean ± SD

Median (%25)–(%75)

C

0.54±0.25

0.56 (0.27)–(0.78)

CP

–0.30 ± 0.29

–0.39 (–0.43)–(–0.03)***

NaHS25

–0.11±0.22

–0.03 (–0.35)–(0.10)

NaHS50

–0.45±0.22

–0.38 (–0.62)–(–0.30)***

NaHS100

–0.21±0.16

–0.30 (–0.32)–(–0.04)***

C

0.16±0.04

0.15 (0.12)–(0.19)

CP

0.43±0.28

0.39 (0.23)–(0.71)

NaHS25

0.46±0.44

0.31 (0.23)–(0.46)

NaHS50

0.27±0.26

0.16 (0.08)–(0.44)

NaHS100

0,16±0.08

0.16 (0.08)–(0.22)

C

0.14±0.02

0.14 (0.13)–(0.16)

CP

0.17±0.06

0.15 (0.11)–(0.23)

NaHS25

0.18±0.14

0.14 (0.13)–(0.20)

NaHS50

0.34±0.14

0.38 (0.18)–(0.47)***

NaHS100

0.29±0.12

0.25 (0.20)–(0.33)***

C

4.26±0.61

4.30 (4.15)–(4.75)

CP

6.53±0.56

6.52 (6.01)–(7.08)**

NaHS25

5.52±0.46

5.48 (5.11)–(6.00)**

NaHS50

5.04±1.67

5.87 (3.30)–(6.08)**

NaHS100

4.89±1.46

5.15 (3.42)–(6.25)

C

0.13±0.01

0.13 (0.13)–(0.14)

CP

0.19±0.07

0.17 (0.15)–(0.24)

NaHS25

0.36±0.58

0.16 (0.15)–(0.17)

NaHS50

0.16±0.01

0.16 (0.15)–(0.18)

NaHS100

0.16±0.02

0.16 (0.14)–(0.17)

p

<0.001

0.022

0.001

0.002

0.007

Values are given as mean ± SD and median (%25)–(%75). Differences are given compared to the C group (*).
** p < 0.01; *** p < 0.001.
C: control; CP: cyclophosphamide; NaHS: sodium hydrosulfide.

3.2.4. Follicle stimulating hormone (FSH), luteinizing
hormone (LH), and testosterone (T) values
Follicle stimulating hormone (FSH), luteinizing hormone
(LH), and testosterone (T) values are shown in Figure
2. The FSH values had no differences observed between
the groups. However, when the LH values are examined,
there was a significant increase identified in the CP group
compared to the control group (p < 0.001). There were
significant falls identified in the other treatment groups
compared to both control and CP groups (p < 0.001).
When testosterone levels are investigated, there was a
significant reduction observed in the CP group (p < 0.001).
When the values in the 25 and 50 µmol/kg NaHS groups
are investigated, there was a increase in testosterone values
compared to the CP group (p < 0.001). The value in the

100 µmol/kg NaHS group was significantly low compared
to the NaHS50 group (p < 0.001). However, testosterone
levels were only identified to reach control levels in the
NaHS50 group. This group was not identified to have any
significance compared to control.
3.2.5. Histopathologic values
3.2.5.1. Bladder hematoxylin & eosin (H&E) staining
Bladder hematoxylin & eosin (H&E) staining is shown
in Figure 3. Bladder preparates stained with H & E had
normal bladder epithelium appearance in the control
group. In the CP group, bladder mucosa epithelium
had mild degree of desquamation, severe hemorrhage
in lamina propria and submucosa, and mild levels of
inflammatory cell inflammation observed (grade 2). In
the NaHS25 group, the bladder epithelium had partially
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Figure 1. Effects of NaHS treatment on biochemical parameters in rats with cyclophosphamide toxicity. A: IL10 testis; B: IL10 bladder;
C: IL 6 testis; D: IL 6 bladder. Data are given as mean ± SD. (*): Different from control; ** p < 0.01; (+); Different from CP; ++ p < 0.01
ANOVA (n: 8). C: control; CP: cyclophosphamide; NaHS: sodium hydrosulfide; IL: interleukin.

normal appearance with severe hemorrhage in the lamina
propria and submucosa and mild levels of inflammatory
cell infiltration similar to the CP group. The NaHS50
group had bladder epithelium with appearance close to
the control group for lamina propria and submucosa
(grade 0). The NaHS100 group had less desquamation
of bladder epithelium compared to the CP group, and
milder hemorrhage in lamina propria and submucosa and
inflammatory cell infiltration compared to the NaHS25
group (grade 1).
3.2.5.2. Bladder immunohistochemical staining
Bladder immunohistochemical staining is shown in
Figure 4, Figure 5, Figure 6, and Figure 7. Apoptotic cell
counts with immunohistochemical staining observed an
increase in apoptotic cell numbers especially in the CP
group (Figure 4, Figure 5, and Figure 6). Additionally, a
notable finding is that the NaHS50 group had a significant
reduction in apoptotic cell counts compared to the CP
group (Figure 4, Figure 5, and Figure 6).
Acrolein staining did not observe any areas stained for
acrolein in the control group bladder (Figure 7). However,
very darkly stained areas were present in the CP group
(Figure 7). In the treatment groups, the group with least
acrolein staining was observed to be the NaHS50 group
(Figure 7).
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3.2.5.3. Testis H&E staining
Testis H&E staining is shown in Figure 8, Figure 9.
Histological investigation of testis tissue found testis
sections from the control group contained seminiferous
tubules, cells belonging to spermatogenic series and
Leydig cells in interstitial tissue had normal structure and
no pathologic findings were encountered (Figure 8). Testis
sections from the CP group observed intense hemorrhage
and edema in the interstitial area, increased seminiferous
tubule numbers with germinal cells falling into the
lumen, occasional vacuolization in germinal epithelium,
and reduced thickness of germinal epithelium (Figure
8). Testis sections from the NaHS25 group observed an
improvement in hemorrhage and edema in the interstitial
area seen in the CP group, with similar increases in
seminiferous tubules falling from germinal cells into the
lumen and reductions in germinal epithelium thickness
(Figure 8). Sections from the NaHS50 group had occasional
hemorrhage and edema in the interstitial area, with germ
cell counts falling into the lumen in seminiferous tubules
and germinal epithelium thickness similar to the control
group (Figure 8). The NaHS100 group had hemorrhage
and edema in the interstitial area rarely but occasionally,
and vacuolization in germinal epithelium, with germ cell
numbers falling into the lumen in seminiferous tubules
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Table 2. cGMP, NO, H2S bladder and testis values.

Bladder

cGMP
Testis

Bladder

NO
Testis

Bladder

H2S
Testis

Group

Mean ± SD

Median (%25)–(%75)

p

C

315.09±79.56

304.30 (243.33)–(378.13)

CP

195.70±19.71

196.44 (178.21)–(212.35)**

NaHS25

221.97±30.31

218.92 (201.67)–(246.83)**

NaHS50

224.78±37.6

239.34 (190.00)–(255.00)**

NaHS100

287.62±66.38

295.45 (215.72)–(338.75)

C

23.28±16.22

15.62 (10.62)–(42.14)

CP

5.72±2.51

5.35 (4.32)–(7.27)

NaHS25

18.90±10.59

15.81 (10.82)–(29.23)++

NaHS50

37.68±15.86

38.30 (22.51)–(52.15)++

NaHS100

32.83±23.56

26.53 (11.13)–(61.10)

C

24.73±9.48

21.88 (17.54)–(36.09)

CP

18.70±3.89

19.09 (14.38)–(22.38)

NaHS25

25.85±7.16

25.23 (20.50) –(31.67)

NaHS50

32.15±6.24

31.59 (26.56)–(38.85)*+

NaHS100

26.21±9.06

25.86 (17.38)–(36.17)*+^

C

0.71±0.52

0.71 (0.17)–(1.13)

CP

0.46±0.28

0.36 (0.25)–(0.68)

NaHS25

1.04±0.43

1.04 (0.80)–(1.44)

NaHS50

1.74±0.48

2.03 (1.13)–(2.07)**++

NaHS100

0.91±0.45

0.97 (0.42)–(1.30)^^

C

79.04±18.24

76.34 (61.36)-(96.81)

CP

60.81±26.03

65.00 (42.05)-(76.67)

NaHS25

78.93±22.47

79.67 (58.65)-(100.68)

NaHS50

108.14±37.98

117.69 (77.11)-(134.13)**++

NaHS100

116.37±20.73

116.59 (95.15)-(138.64)**

C

0.94±0.56

0.92 (0.39)–(1.44)

CP

0.64±0.40

0.54 (0.30)–(1.03)

NaHS25

1.29±0.27

1.18 (1.12)–(1.48)***+++

NaHS50

1.99±0.35

2.12 (1.64)–(2.29)***+++

NaHS100

2.43±0.77

2.61 (1.87)–(3.05)***+++

0.009

++

0.002

++

0.05

0.006

0.019

++

0.001

Values are given as mean ± SD and median (%25)–(%75). Differences are given compared to the C group (*), CP
group (+), NaHS50 (^). * p < 0.05; ** p < 0.01; *** p < 0.001,
+
p < 0.05; ++ p < 0.01; +++ p < 0.001, ^ p < 0.05; ^^ p < 0.01.
C: control; CP: cyclophosphamide; NaHS: sodium hydrosulfide.

and germinal epithelium thickness similar to the control
group (Figure 8).
Tubuloseminiferous epitelyal height was reduced in
the CP group compared to the control group (p < 0.001).
In the NaHS50 group, there was a significant increase
observed compared to the CP group (p < 0.001) (Figure 9).
3.2.5.4. Testis immunohistochemical staining
Testis immunohistochemical staining is shown in Figure

10. Immunohistochemical staining observed increased
apoptotic cell counts especially in the CP group. The
NaHS50 group was observed to have a significant reduction
in apoptotic cell counts compared to the CP group.
4. Discussion
In this study we aimed to investigate the therapeutic and
protective effects of H2S against hemorrhagic cystitis
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Figure 2. Effects of NaHS treatment on hormonal parameters in rats with cyclophosphamide toxicity. Data
are given as mean ± SD. (*): different from control ; *** p < 0.001; (+); different from CP; +++ p < 0.001; (^):
different from NaHS50; ^^^ p < 0.001 ANOVA (n: 8). C: control; CP: cyclophosphamide; NaHS: sodium
hydrosulfide; FSH: follicle stimulating hormone; LH: luteinizing hormone; T: testosterone.

Figure 3. Representative images of H&E staining in the bladder. C: control; CP: cyclophosphamide; NaHS: sodium hydrosulfide.

and testicular injury, serious side effects of the anticancer
cyclophosphamide, in male rats. So, we investigated IL 6,
IL 10, cGMP, NO, H2S, FSH, LH, and testosterone values.
We identified a significant fall in IL 6 and IL 10 values,
especially in the testes of treatment groups administered
25 and 50 µmol/kg NaHS. However, a significant increase
was present in the group administered CP. Stimulation
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of the bladder with CP causes excessive inflammation.
As a result, the increase in IL 6 levels in the CP group is
accepted as normal. In fact, a study identified that CP
increased IL 6 levels [19]. IL 6 expression is linked to
protein kinase signaling activated by p38-mitogen and
c-jun pathway activated by NF k B. H2S is known to
have a regulatory role in inflammation. A study of cattle
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Figure 4. Representative images of APAF-1 staining in the bladder. C: control; CP: cyclophosphamide; NaHS: sodium hydrosulfide.

Figure 5. Effects of NaHS treatment on immunohistochemical parameters in rats with
cyclophosphamide toxicity. Data are given as mean ± SD. (*): Different from control
; *** p < 0.001; (+); Different from CP; +++ p < 0.001 ANOVA (n: 8). C: control; CP:
cyclophosphamide; NaHS: sodium hydrosulfide.

mammary infections identified exogenously-administered
H2S lowered IL 6 levels [20]. Similar results were obtained
in our study. In the testes, pronounced falls in IL 10 and
IL 6 levels were observed, especially with 50 µmol/kg
NaHS dose. Interestingly, these levels were lower than the
levels with dose of 100 µmol/kg NaHS. The IL 6 and IL 10
levels increased with administration of 100 µmol/kg NaHS

dose. We observed the same effects in our study as in our
previous study where we researched the effective dose of
exogenous H2S [21].
Used as a secondary messenger in signal transduction
pathways, cGMP regulates a variety of physiologic
functions. Smooth muscle contractility, neurotransmission
and cell growth and proliferation may be listed among
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Figure 6. Representative images of Caspase-3 staining in the bladder. C: control; CP: cyclophosphamide; NaHS: sodium hydrosulfide.

Figure 7. Representative images of Acrolein staining in the bladder. C: control; CP: cyclophosphamide; NaHS: sodium hydrosulfide.

these functions. In our study, we observed cGMP levels fell
in both bladder and testis tissue with administration of CP.
In fact, we observed similar results in our previous study.
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A study by De Oliviera et al. [22] induced cystitis in mice
with CP and investigated the effects of an agent named
BAY 58-2668 on cystitis. The researchers observed that
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Figure 8. Representative images of H&E staining in the testis. C: control; CP: cyclophosphamide; NaHS: sodium hydrosulfide.

Figure 9. Effects of NaHS treatment on histological parameters in rats with
cyclophosphamide toxicity. Data are given as mean ± SD. (*): Different from control
; *** p < 0.001; (+); Different from CP; +++ p < 0.001 ANOVA (n: 8). C: control; CP:
cyclophosphamide; NaHS: sodium hydrosulfide.

CP caused a fall in cGMP levels. However, the agent called
BAY 58-2667 did not ameliorate this effect and as a result
did not improve bladder functions. This study was similar
to our study. There was no study encountered investigating
the effects of H2S. We observed that cGMP levels fell in
the group administered CP and that the cGMP levels
increased in the groups administered NaHS. In testis tissue
the 50 µmol/kg NaHS dose was effective especially, while
in bladder tissue all three doses were effective; however, we
observed the most effective dose was 100 µmol/kg NaHS.

When we examined NO and H2S values, we observed
NO values were increased in both bladder and testis of
the group administered 50 µmol/kg NaHS. The formation
of the guanyl cyclase enzyme, which converts GTP to
c-GMP, is accelerated by NO, carbon monoxide (CO)
and natriuretic peptide (NUP). A small molecule, NO
is formed with the help of nitric oxide synthase (NOS)
enzyme in the presence of L-arginine and oxygen [23]. NO
released from urothelium or nerve fibers affects efferent
and afferent neurotransmission. This causes inhibitory
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Figure 10. Representative images of Acrolein staining in the testis. C: control; CP: cyclophosphamide; NaHS: sodium hydrosulfide.

effects in bladder smooth muscle. NO nucleoside has the
effect of increasing catalytic activity of enzyme-soluble
guanyl cyclase (sGC), a cytosolic, heterodimeric protein
comprising α - and β-subunits and a protetic heme
group including a β-subunit transforming GTP to cGMP
[22]. Once formed, NO enters the smooth muscle cell,
it increases the level of cGMP over the soluble guanyl
cyclase enzyme, the second increased messenger molecule
(cAMP and cGMP) within the cytoplasm stimulates the
protein kinase enzyme in the cell and finally, Ca level
decreases in cytoplasm and smooth muscle relaxation is
provided [23]. In other words, cGMP and NO are linked
to each other. Studies have shown a common signal path
mediating the effects of NO and H2S on vascular functions
like vasodilatation, vascular remodeling (migration and
proliferation), and angiogenesis. Recent studies have
shown H2S-mediated NO regulation has a role in regulating
angiogenesis and reducing ischemia-reperfusion injury.
Kolluru et al. [24] explained the protective effects of
H2S and donors against proangiogenic and ischemia/
reperfusion injury may occur via induction of effectors in
the VEGF/VEGFR2 signals and vascular endothelial cells
PI3K/Akt/eNOS. Additionally, H2S prevents degradation
of eNOS and later is reported to induce NO production
by eNOS phosphorylation via PI3K/Akt activity and p38
MAPK pathway mediation. The pharmacologic donors
of NO upregulate substrate bioavailability and expression
for the H2S synthesis enzyme CSE and may result in H2S
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production occurring with vasodilator effects [24]. This
information complies with the results of our study.
We observed H2S increased in a dose-dependent
manner in testis tissue. However, when we examined
bladder tissue, the highest level of H2S was observed in
the group administered 50 µmol/kg NaHS. This result
seems that this dose was effective for hemorrhagic cystitis.
H2S is an effective gasotransmitter in both bladder and
testis. Both CBS and CSE are expressed in the human
corpus cavernosum. Exogenously-administered H2S was
observed to relax isolated corpus cavernosum endothelium
independently. The testis is a structure sensitive to oxidative
stress. A study by Wang et al. [25] identified a reduction in
H2S concentrations in seminal plasma of infertile patients.
Administration of H2S externally was identified to resolve
this problem. Finally, they concluded that exogenous H2S
protected testicular function and was effective in terms of
fertility.
H2S is predicted to be effective in the bladder.
Cystathionine synthase is expressed in the human bladder
and produces H2S at identifiable rates in vitro. Additionally,
H2S is a mediator of the smooth muscle relaxant effect of
phosphodiesterase 5 (PDE-5) [26]. At the same time, H2S
may be produced endogenously in rat and mouse bladders.
Animal studies have shown that H2S is effective on bladder
smooth muscle relaxation. This effect of H2S occurs by
activation of the potassium-ATP dependent channel in the
human bladder. Both CSE and CBS enzyme are expressed

ÖZATİK et al. / Turk J Med Sci
in human urothelium and detrusor muscle and produce
H2S. CBS regulates phosphorylation activity within
urothelium. This enzyme makes phosphorylation more
active dependent on cyclic guanosine monophosphate/
protein kinase (cGMP/PKG) especially in Ser 227. Stated
differently, when there is an increase in cGMP, there is
also an increase for H2S and this relaxes the bladder [27].
These results comply with the results of our study. In our
study we observed a significant increase in H2S levels in
the bladder, especially in the group administered 50 µmol/
kg NaHS. Additionally, when compared with the CP
groups, we observed significant increases in cGMP levels.
According to these results, the administered NaHS as H2S
donor can be said to have protective and therapeutic effect
on toxicity induced by CP in the bladder and testis.
Additionally, we investigated FSH, LH and
testosterone levels to assess testis functions. LH values
were higher in the group administered CP; however,
testosterone levels were low. This result complies with the
results of previous studies. In fact, a study which induced
dyszoospermia with CP obtained the same results [28].
When we look at the treatment groups, the decrease in
testosterone values in CP group were found to increase.
We determined that the closest rise to the control values
was in the group in which we administered 50 µmol/kg
NaHS. In the group administered 100 µmol/kg NaHS,
we observed LH levels began to rise and testosterone
levels began to fall again. According to these results, we
can say H2S has a positive effect on testis dysfunction.
LH is a hormone produced by the pituitary gland in the
brain. In males, LH causes production of testosterone
by stimulating Leydig cells in the testes. After testis
dysfunction induced by CP, it is natural that testosterone
production will stop or reduce. On the contrary, the
pituitary gland begins to produce more LH. Considering
the increase in testosterone levels with of, exogenous H2S
may be concluded to be effective on cases with drug-

related infertility. In fact, histologic and histopathologic
results comply with these findings.
In our study, we performed histologic staining with
H&E. The findings here support our biochemical results.
Very intense hemorrhagic foci were observed in the CP
group, while appearances close to the control group
were observed in the NaHS50 group especially [29].
We used APAF-1, caspase-3, and acrolein staining for
immunohistochemical studies. APAF-1 and caspase 3
staining provided results compatible with H&E staining.
Here, the apoptotic cell counts were increased in the CP
group; however, we identified these numbers were much
reduced especially in the NaHS50 group. These results
were the same for both bladder and testis.
When all these findings are evaluated, H2S has
protective and therapeutic effects on hemorrhagic cystitis
and testis dysfunction developing linked to the cancer drug
CP. Medications developed with this gasotransmitter will
protect cancer patients from the side effects of drugs and/
or treat the side effects caused by drugs with the effective
dose of 50 µmol/kg. H2S is a promising molecule for the
development of new medications.
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